Results 11 to 20 of about 8,404 (212)

Acute Intermittent Porphyria in a Man with Dual Enzyme Deficiencies

open access: yesCase Reports in Genetics, 2020
Porphyrias are a heterogeneous group of metabolic disorders that result from the altered activity of specific enzymes of the heme biosynthetic pathway and are characterized by accumulation of pathway intermediates.
G. N. Cerbino   +6 more
doaj   +2 more sources

Acute Intermittent Porphyria: Current Perspectives And Case Presentation

open access: yesTherapeutics and Clinical Risk Management, 2019
Zachary Spiritos,1 Shakirat Salvador,2 Diana Mosquera,3 Julius Wilder1,4 1Department of Medicine, Division of Gastroenterology, Duke University School of Medicine, Durham, NC, USA; 2Department of Medicine, Division of Gastroenterology, Vanderbilt ...
Spiritos Z   +3 more
doaj   +1 more source

Feigning Acute Intermittent Porphyria [PDF]

open access: yesCase Reports in Psychiatry, 2014
Acute intermittent porphyria (AIP) is an autosomal dominant genetic defect in heme synthesis. Patients with this illness can have episodic life-threatening attacks characterized by abdominal pain, neurological deficits, and psychiatric symptoms. Feigning
Rania Elkhatib   +5 more
doaj   +2 more sources

Radiopharmaceuticals in Acute Porphyria [PDF]

open access: yesClinical Therapeutics, 2016
Purpose: The acute porphyrias are a group of rare metabolic disorders of the heme biosynthetic pathway. Carriers of the acute porphyria gene are prone to potentially fatal acute attacks, which can be precipitated by drug exposure.
Mamedova, Ilahä   +3 more
core   +3 more sources

Acute Hepatic Porphyria [PDF]

open access: yesJournal of Clinical and Translational Hepatology, 2015
The porphyrias comprise a set of diseases, each representing an individual defect in one of the eight enzymes mediating the pathway of heme synthesis. The diseases are genetically distinct but have in common the overproduction of heme precursors.
Wang, Bruce, Bissell, D Montgomery
core   +6 more sources

An update of clinical management of acute intermittent porphyria

open access: yesThe Application of Clinical Genetics, 2015
Elena Pischik,1,2 Raili Kauppinen,11Porphyria Research Unit, Division of Endocrinology, Department of Medicine, University Central Hospital of Helsinki, Helsinki, Finland; 2Department of Neurology, Consultative and Diagnostic Centre with Polyclinics, St ...
Pischik E, Kauppinen R
doaj   +1 more source

Post- Partum Acute Intermittent Porphyria - A Case Report

open access: yesThe Indian Anaesthetists' Forum, 2010
Porphyrias are inherited disorders, each involving a specific enzyme in heme biosynthetic pathways. Acute intermittent porphyria, one of the hepatic porphyria is the most severe form of the disease, with gastrointestinal and neuropsychiatric ...
Gaurav Tomar   +3 more
doaj   +1 more source

Management of hyponatremia associated with acute porphyria-proposal for the use of tolvaptan. [PDF]

open access: yesAnn Transl Med, 2020
Hyponatremia is a common feature during the neurovisceral acute attacks which characterize hepatic porphyrias, as well as a sign of its severity.
Solares I   +6 more
europepmc   +2 more sources

THE ACUTE PORPHYRIAS

open access: yesInternational Journal of Clinical Practice, 1993
SUMMARYThe porphyrias are a heterogeneous group of rare inborn errors of metabolism caused by inherited enzyme defects in the haem biosynthetic pathway, resulting in overproduction of porphyrins. The porphyrias can be distinguished biochemically but may be difficult to differentiate clinically.
G Y, Lip, K E, McColl, M R, Moore
openaire   +2 more sources

The diagnosis and management of porphyria cutanea tarda (PCT)

open access: yesSouth African Family Practice, 2009
The porphyrias are a group of disorders in which excessive quantities of porphyrins or their precursors are produced. They are due to abnormalities in the control of the porphyrin-haem metabolic pathway.
Mojakgomo H. Motswaledi
doaj   +1 more source

Home - About - Disclaimer - Privacy